Literature DB >> 24647983

Prevalence and clinical manifestations of ankylosing spondylitis in young Greek males.

D G Kassimos1, J Vassilakos, G Magiorkinis, A Garyfallos.   

Abstract

Increased awareness and sensitivity of general physicians have increased the early diagnoses of seronegative arthritis in young patients, while new agents such as anti-TNF blockers have significantly changed the treatment of the disease. To investigate the prevalence, the clinical manifestations, and the ability for military service of young Greek males (18-30 years old) with ankylosing spondylitis (AS) in the pre-anti-TNF era. We retrospectively studied the AS cases recorded from 1989 to 1995 of the rheumatology department of the largest General Military Hospital in Greece; the diagnosis was based on the modified New York criteria for AS. A total of 285 AS cases were diagnosed among 357,184 young men. The overall prevalence of AS on December 1995 was estimated at 8.2 cases per 10,000 young men (95 % C.I. 7.2-9.2). All the patients had chronic back pain. Two hundred forty (84 %, 95 % C.I. 79-88 %) patients presented sacroiliitis of whom 163 (68 %, 95 % C.I. 62-73 %) were bilateral. Two hundred five patients (72 %, 95 % C.I. 66-77 %) had peripheral joint involvement. Thirty-one patients presented with anterior uveitis (11 %, 95 % C.I. 8-15 %). One patient had IgA nephropathy. None had gut involvement. HLA-B27 antigen was found in 257 patients (90 %, 95 % C.I. 86-93 %). Ninety-one patients (32 %, 95 % C.I. 27-38 %) had permanent discharge from the military service, while 128 (45 %, 95 % C.I. 39-51 %) were able for auxiliaries attendances. The prevalence of AS for the age group 18-30 years old in this young Greek men cohort was significantly lower than in other Caucasian European populations, and the clinical manifestations were considered as mild.

Entities:  

Mesh:

Year:  2014        PMID: 24647983     DOI: 10.1007/s10067-014-2574-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

2.  Delay in diagnosis of spondarthritis.

Authors:  B L Kidd; M I Cawley
Journal:  Br J Rheumatol       Date:  1988-06

Review 3.  The epidemiology of ankylosing spondylitis.

Authors:  J T Gran; G Husby
Journal:  Semin Arthritis Rheum       Date:  1993-04       Impact factor: 5.532

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Roentgenological features of ankylosing spondylitis. A comparison between patients attending hospital and cases selected through an epidemiological survey.

Authors:  J T Gran; M Hordvik; G Husby
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

6.  Some problems in rehabilitation in the services. Management of ankylosing spondylitis.

Authors:  C B Wynn Parry
Journal:  Proc R Soc Med       Date:  1966-07

7.  Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect.

Authors:  M A Brown; A Jepson; A Young; H C Whittle; B M Greenwood; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

Review 8.  Update: the twenty subtypes of HLA-B27.

Authors:  M A Khan
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

9.  Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors.

Authors:  S Brophy; S Pavy; P Lewis; G Taylor; L Bradbury; D Robertson; C Lovell; A Calin
Journal:  J Rheumatol       Date:  2001-12       Impact factor: 4.666

10.  Predictors of longterm outcome in ankylosing spondylitis.

Authors:  Michele F Doran; Sinead Brophy; Kirsten MacKay; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

View more
  5 in total

Review 1.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

Review 2.  An infected Andersson lesion presented with incomplete paraplegia in a patient with ankylosing spondylitis. A unique case report with literature review.

Authors:  Ioannis Papaioannou; Georgia Pantazidou; Thomas Repantis; Andreas Baikousis; Panagiotis Korovessis
Journal:  Spinal Cord Ser Cases       Date:  2022-08-09

3.  Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS.

Authors:  Nisha N Haroon; J Michael Paterson; Ping Li; Nigil Haroon
Journal:  BMJ Open       Date:  2014-12-15       Impact factor: 2.692

4.  Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis.

Authors:  Li Zhang; Hui Ouyang; Zhen Xie; Zhi-Hui Liang; Xiong-Wen Wu
Journal:  Exp Mol Med       Date:  2016-04-22       Impact factor: 8.718

Review 5.  The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science.

Authors:  Abdulla Watad; Charlie Bridgewood; Tobias Russell; Helena Marzo-Ortega; Richard Cuthbert; Dennis McGonagle
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.